Skip to content
Trial Eligibility
Menu

Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients

NCT04753996

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this research is to create a collection of bile, bile duct brushings and medical information from people with Primary Sclerosing Cholangitis (PSC) and controls to learn more about changes that occur in the liver.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Primary Sclerosing Cholangitis
  • PSC
  • Cholangiocarcinoma

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 85 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Mayo Clinic
Last updated on ClinicalTrials.gov
February 17, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Minnesota · 1

  • Mayo Clinic in Rochester · Rochester, MN

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.